Compare stocks

Oxford Nanopore Technologies plc, trading under the ticker ONT, operates in the biotechnology sector, focusing on the development of nanopore technology for DNA and RNA sequencing. Founded in 2005 and publicly listed, the company's innovative technology facilitates real-time, scalable, and accessible biological research, with applications ranging from healthcare to environmental science. Based in the UK, Oxford Nanopore has revolutionized the approach to molecular analysis by providing a direct and electric characterization of single molecules.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.